94 related articles for article (PubMed ID: 16555429)
21. [Genefec--what is it to be used for?].
Baatrup G
Tidsskr Nor Laegeforen; 2006 Jun; 126(12):1626-7; author reply 1627. PubMed ID: 16770384
[No Abstract] [Full Text] [Related]
22. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
[TBL] [Abstract][Full Text] [Related]
23. [Genefec--one more time].
Baatrup G
Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2547; author reply 2547. PubMed ID: 17028640
[No Abstract] [Full Text] [Related]
24. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.
Ewald N; Schaller M; Bayer M; Akinci A; Bretzel RG; Kloer HU; Hardt PD
Anticancer Res; 2007; 27(4A):1949-52. PubMed ID: 17649802
[TBL] [Abstract][Full Text] [Related]
25. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive detection of colorectal cancer by molecular tools: coming of age.
Dutta SK; Nair PP
Gastroenterology; 1998 Jun; 114(6):1333-5. PubMed ID: 9618652
[No Abstract] [Full Text] [Related]
27. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.
Ahlquist DA
BMJ; 2000 Jul; 321(7256):254-5. PubMed ID: 10915110
[No Abstract] [Full Text] [Related]
28. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
29. New stool screening tests for colorectal cancer.
Young GP; Cole S
Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
[TBL] [Abstract][Full Text] [Related]
30. Screening, surveillance, and prevention of colorectal cancer.
Lieberman D
Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):595-605, xi. PubMed ID: 18674706
[TBL] [Abstract][Full Text] [Related]
31. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
32. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
33. PCR-based assessment of the recovery rate of exfoliated colonocytes or cancer cells from fecal samples depends on the storage conditions after defecation.
Onouchi S; Matsushita H; Nomura S; Minowa T; Matsumura Y
J Gastrointestin Liver Dis; 2007 Dec; 16(4):369-72. PubMed ID: 18193116
[TBL] [Abstract][Full Text] [Related]
34. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
35. Implementation of colon cancer screening: techniques, costs, and barriers.
Miller AB
Gastroenterol Clin North Am; 2008 Mar; 37(1):83-95, vi. PubMed ID: 18313541
[TBL] [Abstract][Full Text] [Related]
36. [Screening for colorectal cancer: definitely implement].
Jansen JB
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1776. PubMed ID: 18754309
[TBL] [Abstract][Full Text] [Related]
37. Colon cancer: an update on screening.
Brenneman AE;
JAAPA; 2008 Mar; 21(3):17-8. PubMed ID: 18432042
[No Abstract] [Full Text] [Related]
38. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
39. [Screening the population for colorectal cancer: the background to a number of pilot studies in the Netherlands].
van Rijn AF; Dekker E; Kleibeuker JH
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2739-44. PubMed ID: 17225784
[TBL] [Abstract][Full Text] [Related]
40. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
